WINDSOR JAMES BRIAN 4
4 · TFF Pharmaceuticals, Inc. · Filed Oct 29, 2019
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
- Award
Stock Options (Right to Buy)
2019-10-29+43,794→ 135,806 totalExercise: $5.00Exp: 2029-10-29→ Common Stock (43,794 underlying) - Purchase
Common Stock
2019-10-25$5.00/sh+5,000$25,000→ 5,000 total
Footnotes (2)
- [F1]The shares of common stock purchased in the Issuer's initial public offering.
- [F2]25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.